Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up
- PMID: 28852317
- PMCID: PMC5558121
- DOI: 10.3748/wjg.v23.i30.5579
Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up
Abstract
Aim: To retrospectively evaluate the factors that influence long-term outcomes of duodenal papilla carcinoma (DPC) after standard pancreaticoduodenectomy (SPD).
Methods: This is a single-centre, retrospective study including 112 DPC patients who had a SPD between 2006 and 2015. Associations between serum levels of CA19-9 and CEA and various clinical characteristics of 112 patients with DPC were evaluated by the χ2 test and Fisher's exact test. The patients were followed-up every 3 mo in the first two years and at least every 6 mo afterwards, with a median follow-up of 60 mo (ranging from 4 mo to 168 mo). Survival analysis was conducted using the Kaplan-Meier survival and Cox proportional hazards model analysis. The difference in survival curves was evaluated with a log-rank test.
Results: In 112 patients undergoing SPD, serum levels of CA19-9 was associated with serum levels of CEA and drainage mode (the P values were 0.000 and 0.033, respectively); While serum levels of CEA was associated with serum levels of CA19-9 and differentiation of the tumour (the P values were 0.000 and 0.033, respectively). The serum levels of CA19-9 and CEA were closely correlated (χ² = 13.277, r = 0.344, P = 0.000). The overall 5-year survival was 50.00% for 112 patients undergoing SPD. The Kaplan-Meier survival analysis showed that increased serum levels of CA19-9, CEA, and total bilirubin were correlated with a poor prognosis, as well as a senior grade of infiltration depth, lymph node metastases, and TNM stage(the P values were 0.033, 0.018, 0.015, 0.000, 0.000 and 0.000, respectively). Only the senior grade of infiltration depth and TNM stage retained their significance when adjustments were made for other known prognostic factors in Cox multivariate analysis (RR = 2.211, P = 0.022 and RR = 2.109, P = 0.047).
Conclusion: For patients with DPC, the serum levels of CA19-9 and CEA were closely correlated, and play an important role in poor survival. Increased serum levels of total bilirubin and lymph node metastases were also correlated with a poor prognosis. The senior grade of infiltration depth and TNM stage can serve as independent prognosis indexes in the evaluation of patients with DPC after SPD.
Keywords: CA19-9; CEA; Duodenal papilla carcinoma; Pancreaticoduodenectomy; Survival.
Conflict of interest statement
Conflict-of-interest statement: We declare that there are no conflicts of interest to disclose.
Figures

Similar articles
-
The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.Hepatogastroenterology. 2014 Jun;61(132):994-9. Hepatogastroenterology. 2014. PMID: 26158155
-
Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.Int J Biol Markers. 2013 Jun 28;28(2):192-200. doi: 10.5301/jbm.5000023. Int J Biol Markers. 2013. PMID: 23787496
-
Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.Int J Clin Exp Pathol. 2015 Nov 1;8(11):14853-63. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823815 Free PMC article.
-
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.Eur J Surg Oncol. 2005 Mar;31(2):164-9. doi: 10.1016/j.ejso.2004.09.007. Eur J Surg Oncol. 2005. PMID: 15698733
-
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.Anticancer Res. 2000 Nov-Dec;20(6D):5195-8. Anticancer Res. 2000. PMID: 11326694
Cited by
-
Development and validation of web calculators to predict early recurrence and long-term survival in patients with duodenal papilla carcinoma after pancreaticoduodenectomy.BMC Cancer. 2023 Nov 20;23(1):1129. doi: 10.1186/s12885-023-11632-5. BMC Cancer. 2023. PMID: 37985973 Free PMC article.
-
Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma.Dis Markers. 2019 Feb 4;2019:6016931. doi: 10.1155/2019/6016931. eCollection 2019. Dis Markers. 2019. PMID: 30863466 Free PMC article.
-
Identification of critical pathways and potential therapeutic targets in poorly differentiated duodenal papilla adenocarcinoma.Cancer Cell Int. 2021 Jan 6;21(1):9. doi: 10.1186/s12935-020-01709-7. Cancer Cell Int. 2021. PMID: 33407508 Free PMC article.
-
Prognostic Value of the Regional Lymph Node Station in Pancreatoduodenectomy for Ampullary Carcinoma.In Vivo. 2022 Mar-Apr;36(2):973-978. doi: 10.21873/invivo.12789. In Vivo. 2022. PMID: 35241558 Free PMC article.
-
Diagnosis and Treatment of Synchronous Lymphoma and Digestive System Carcinoma: Report of Four Cases and Literature Review.Front Oncol. 2019 Dec 10;9:1367. doi: 10.3389/fonc.2019.01367. eCollection 2019. Front Oncol. 2019. PMID: 31921632 Free PMC article.
References
-
- DeOliveira ML, Triviño T, de Jesus Lopes Filho G. Carcinoma of the papilla of Vater: are endoscopic appearance and endoscopic biopsy discordant? J Gastrointest Surg. 2006;10:1140–1143. - PubMed
-
- Kim MH, Lee SK, Seo DW, Won SY, Lee SS, Min YI. Tumors of the major duodenal papilla. Gastrointest Endosc. 2001;54:609–620. - PubMed
-
- Di Giorgio A, Alfieri S, Rotondi F, Prete F, Di Miceli D, Ridolfini MP, Rosa F, Covino M, Doglietto GB. Pancreatoduodenectomy for tumors of Vater’s ampulla: report on 94 consecutive patients. World J Surg. 2005;29:513–518. - PubMed
-
- Moriya T, Kimura W, Hirai I, Mizutani M, Ma J, Kamiga M, Fuse A. Nodal involvement as an indicator of postoperative liver metastasis in carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg. 2006;13:549–555. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical